click below
click below
Normal Size Small Size show me how
Spring '26 BDK 7
ID 1-2, CV4, Renal
| Pharmacologic Category | Generic Name | Brand Name | Classification | Common Indications |
|---|---|---|---|---|
| Beta-lactam antibiotic (natural penicillin) | penicillin V potassium (PO), penicillin G potassium (IV) | --- | Pharyngitis, SSTI, syphilis (IV/IM) Activity against: Streptococcus pyogenes, Treponema pallidum (syphilis) | |
| Beta-lactam antibiotic (aminopenicillin) | amoxicillin (PO) | --- | Otitis media, pharyngitis Activity against: Streptococcus pneumoniae, Streptococcus pyogenes | |
| Beta-lactam antibiotic and beta-lactamase inhibitor | amoxicillin and clavulanate (PO) | Augmentin, Augmentin XR | Otitis media, bacterial sinusitis Activity against: MSSA, Streptococcus pneumoniae, anaerobes, Enterobacteriaceae | |
| Beta-lactam antibiotic and beta-lactamase inhibitor | ampicillin and sulbactam (IV) | Unasyn | DFI, IAI Activity against: MSSA, Streptococcus pneumoniae, anaerobes, Enterobacteriacae | |
| Beta-lactam antibiotic and beta-lactamase inhibitor | piperacillin and tazobactam (IV) | Zosyn | HAP. VAP, DFI, IAI Activity against: Pseudomonas aeruginosa, anaerobes | |
| Beta-lactam antibiotic (first generation cephalosporin) | cephalexin (PO) | Keflex | SSTI Activity against: MSSA, Streptococcus pyogenes | |
| Beta-lactam antibiotic (first generation cephalosporin) | cefazolin (IV) | Ancef | Antimicrobial prophylaxis in surgery, CRBSI, SSTI Activity against: MSSA, Streptococcus pyogenes | |
| Beta-lactam antibiotic (second generation cephalosporin) | cefuroxime (IV, PO) | IV: Zinacef, PO: Ceftin | CAP, otitis media Activity against: Streptococcus pneumoniae, Haemophilus influenzae | |
| Beta-lactam antibiotic (third generation cephalosporin) | cefdinir (PO) | Omnicef | Otitis media, bacterial sinusitis Activity against: Streptococcus pneumoniae, Haemophilus influenzae | |
| Beta-lactam antibiotic (third generation cephalosporin) | ceftriaxone (IV, IM) | Rocephin | Meningitis, CAP, pyelonephritis Activity against: Streptococcus pneumoniae, Enterobacteriaceae | |
| Beta-lactam antibiotic (fourth generation cephalosporin) | cefepime (IV) | Maxipime | Meningitis, VAP, HAP, pyelonephritis Activity against: Pseudomonas aeruginosa, Enterobacteriaceae | |
| Carbapenem | meropenem (IV) | Merrem | Meningitis, HAP, DFI, IAI Activity against: Pseudomonas aeruginosa, ESBL-producing Enterobacteriaceae | |
| Carbapenem | ertapenem (IV) | Invanz | DFI, IAI Activity against: ESBL-producing Enterobacteriaceae | |
| Fluoroquinolone antibiotic | ciprofloxacin (PO, IV) | Cipro | Pyelonephritis, HAP, VAP Activity against: Pseudomonas aeruginosa, atypicals, Enterobacteriaceae | |
| Fluoroquinolone antibiotic | levofloxacin (PO, IV) | Levaquin | CAP, HAP, VAP, pyelonephritis Activity against: Pseudomonas aeruginosa, Streptococcus pneumoniae, atypicals, Enterobacteriaceae | |
| Fluoroquinolone antibiotic | moxifloxacin (ophthalmic, PO, IV) | Ophthalmic: Vigamox, PO, IV: Avelox | Ophthalmic: bacterial conjunctivitis, PO, IV: CAP Activity against: Streptococcus pneumoniae, atypicals, tuberculosis | |
| Macrolide antibiotic | azithromycin (PO, IV) | Zithromax, Z-Pak, Zmax | CAP Activity against: Chlamydia trachomatis, atypicals | |
| Macrolide antibiotic | fidaxomicin (PO) | Dificid | CDI Activity against: Clostridioides difficile | |
| Tetracycline antibiotic | doxycycline (PO, IV) | Vibramycin | SSTI, CAP, tickborne diseases Activity against: MRSA, atypicals | |
| Tetracycline antibiotic | minocycline (PO, IV) | Minocin | SSTI, acne Activity against: MRSA | |
| Antiarrhythmic | amiodarone (PO, IV) | Pacerone, Nexterone | AF (rhythm control), ventricular fibrillation, ventricular tachycardia | |
| Cholesterol absorption inhibitor | ezetimbe (PO) | Zetia | Dyslipidemia | |
| Fibric acid derivative | fenofibrate (PO) | Tricor, Trilipix | Hypertriglyceridemia | |
| Fibric acid derivative | gemfibrozil (PO) | Lopid | Hypertriglyceridemia | |
| HMG-CoA reductase inhibitor | atorvastatin (PO) | Lipitor | Dyslipidemia, CAD, stroke | |
| HMG-CoA reductase inhibitor | lovastatin (PO) | Altoprev | Dyslipidemia, CAD, stroke | |
| HMG-CoA reductase inhibitor | pravastatin (PO) | Pravachol | Dyslipidemia, CAD, stroke | |
| HMG-CoA reductase inhibitor | rosuvastatin (PO) | Crestor | Dyslipidemia, CAD, stroke | |
| HMG-CoA reductase inhibitor | simvastatin (PO) | Zocor | Dyslipidemia, CAD, stroke | |
| Omega-3 fatty acids | omega-3 ethyl esters (PO) | Lovaza | OTC: available Rx: Lovaza & Vascepa | Hypertriglyceridemia |
| Omega-3 fatty acids | icosapent ethyl (PO) | Vascepa | OTC: available Rx: Lovaza & Vascepa | Hypertriglyceridemia |
| 5 alpha-reductase inhibitor | finasteride (PO) | Proscar, Propecia | BPH, male pattern baldness | |
| Alpha 1 blocker | doxazosin (PO) | Cardura, Cardura XL | BPH, HTN | |
| Alpha 1a blocker | tamsulosin (PO) | Flomax | BPH | |
| Anticholinergic | solifenacin (PO) | Vesicare | Overactive bladder | |
| Anticholinergic, urinary antispasmodic agent | oxybutynin (PO, patch) | PO: Ditropan XL, Patch: Oxytrol, Oxytrol for Women | Patch: OTC | Overactive bladder |
| Beta 3 agonist | mirabegron (PO) | Myrbetriq | Overactive bladder | |
| Urinary analgesic | phenazopyridine (PO) | Pyridium, Azo Urinary Pain Relief | Azo Urinary Pain Relief: OTC | Symptomatic relief of dysuria |
| Electrolyte supplement | magnesium sulfate (IV, IM) | --- | Hypomagnesemia, pre-eclampsia | |
| Electrolyte supplement | potassium chloride (PO, IV) | PO: K-Tab, Klor-Con, Micro-K | PO: OTC available | Hypokalemia |
| Colloid | albumin, 5% or 25% (IV) | Albutein, AlbuRx | Hypovolemia, SBP, paracentesis | |
| Crystalloid | 0.9% sodium chloride (IV) | Normal saline | Hypovolemia | |
| Crystalloid | lactated ringers (IV) | LR | Hypovolemia | |
| Crystalloid | 5% dextrose in water (IV) | D5W | Carrier fluid, hypoglycemia, hypernatremia | |
| Phosphate binder | Calcium acetate (PO) | Calphron, Phosio | Calphron: OTC | Hyperphosphatemia |